Corinne Ferrandini

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Erythropoiesis stimulating agents (ESAs) represent a significant cost for health care establishments, which are now subjected to new restrictions on how these agents can be dispensed, as laid down in the Decree of 24th August 2005 relating to a contract for the proper use of drugs, medical products and services. To optimize the treatment plan, ensure that(More)
  • 1